Barentz, a leading international provider of ingredients to the personal care, human & animal nutrition, pharmaceutical and chemical industries, and NKC, the leading international providers of lanolin and lanolin derivatives for the personal care and pharmaceutical industry, have entered a strategic partnership to strengthen their operations in Europe as well as in the USA
Frankfurt, Germany, November 16, 2012 – During the third international Healthy Ageing Conference in Frankfurt on November 16th, internationally recognized Family Physician Dr. George Kassianos, MD, presented the general practitioner’s point of view on healthy ageing and decreasing the risk of cardio vascular disease.
Barentz international B.V. and Matco Foods Limited officially announce the start of a new Joint Venture in Pakistan, following agreement between both parties. The aim of the new activity is to better serve the rapidly growing Pakistani food processing market with a target group of 200 million citizens.
Matco Foods has built up an extended network within the Pakistan local food industry
Barentz International offers the broadest high-quality ingredients portfolio within the global life science markets
Barentz Pakistan will primarily focus on the markets for Human Nutrition and Pharmaceutical products
Barentz announces today that Cinven has agreed to invest in their company. Cinven is a leading international private equity firm focused on building world-class European and global companies.
Barentz has a strong market position in a structurally growing market for life science ingredients
The Cinven team knows the speciality ingredients distribution market well
Cinven recognizes the opportunities for both organic and buy and build growth
Financial terms of the transaction are not disclosed
Barentz, a leading distributor of ingredients in the life science markets, is pleased to announce it has acquired a majority shareholding in Czech Republic based IMCoPharma.
IMCoPharma is a leader in the pharmaceutical ingredients market in the CIS region and Ukraine
Both Barentz and IMCoPharma are known for their deep technical knowledge and broad portfolio of pharmaceutical ingredients
This strategic investment provides Barentz with the licensing capability to do business with all pharmaceutical companies in this attractive region
IMCoPharma considers this acquisition as an opportunity for strengthening its position in this market and creating new opportunities